FEES Dysphagia Index (FDI) derivation and validation in hospitalized neurological patients
This single-center, retrospective cohort study derived and validated the FEES Dysphagia Index (FDI) in two cohorts of hospitalized neurological patients (n=1,257 and n=1,686). The comparator was the Worst Penetration-Aspiration Scale (PAS) score. The primary outcome was FDI-C performance for clinical outcomes.
For hospital-acquired pneumonia, FDI-C had an AUC of 0.70 versus Worst PAS AUC of 0.60 (p<0.001). For mortality, FDI-C AUC was 0.71 versus Worst PAS AUC of 0.62 (p=0.040). For restricted oral intake, FDI-C AUC was 0.90 versus Worst PAS AUC of 0.74 (p<0.001). FDI-C mapped linearly onto ordinal FOIS values (proportional odds RCS p=0.99). It reconstructed clinician oral intake recommendations with AUC up to 0.93.
Safety and tolerability were not reported. Key limitations include retrospective design, single-center setting, and selection bias addressed but not eliminated. The study is observational; association does not imply causation.
Practice relevance is that FDI-C is a bias-resilient, bedside-calculable score for clinical decision support. However, generalizability beyond neurological inpatients is uncertain, and absolute risk reduction was not reported.